Related Experiment Videos

Bone gamma-carboxyglutamic acid containing protein in the perinatal period

Insights

Fetal bone gamma-carboxyglutamic acid-containing protein (BGP) levels are significantly higher in cord serum than maternal serum, suggesting fetal production and potential bone turnover or vitamin K deficiency influences.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Obstetrics

Background:

  • Bone gamma-carboxyglutamic acid-containing protein (BGP) is a marker of bone metabolism.
  • Maternal and fetal BGP levels during gestation are not well understood.
  • Vitamin K deficiency can affect BGP carboxylation.

Purpose of the Study:

  • To compare BGP, calcium, phosphorus, and alkaline phosphatase levels in paired maternal and cord sera.
  • To measure urinary gamma-Gla in neonates.
  • To investigate potential fetal BGP production and factors influencing its levels.

Main Methods:

  • Measurement of BGP, Ca, P, and Al-P in maternal and cord sera.
  • Quantification of urinary gamma-Gla in neonates.
  • Statistical comparison of serum and urinary analyte concentrations.

Main Results:

  • Cord serum BGP was significantly higher (41.21 ng/ml) than maternal serum BGP (7.44 ng/ml).
  • Maternal BGP levels were comparable to normal adult levels.
  • Urinary gamma-Gla in neonates was 147.68 mumol/g creatinine.
  • No correlation was found between cord and maternal serum BGP.

Conclusions:

  • The elevated cord serum BGP suggests potential fetal BGP production during gestation.
  • Increased fetal bone turnover may contribute to higher BGP levels.
  • Fetal vitamin K deficiency could lead to non-carboxylated BGP in cord serum.

Related Concept Videos